Invest Liverpool City Region

Bronze Sponsor

Liverpool City Region, based in the Northwest of England has been awarded Investment Zone status by UK government, unlocking £80 million of public funding in Health and Life Sciences as well as being formally recognised as a leading hub for vaccine discovery, development and manufacturing. Liverpool City Region is home to CSL Seqirus, AstraZeneca, TriRx, Bristol Myers Squibb, Teva and Pharmaron, supported by the world’s oldest school of tropical medicine and The Pandemic Institute, a global institute accelerating the response to current and future pandemics.